Shilpa Gupta’s Highlights from SIU 2024
The 44th Annual Congress of the Société Internationale d’Urologie (SIU) took place in the vibrant city of New Delhi, India, from October 23 to 26, 2024. This prestigious event brought together over 3,000 urologists and healthcare professionals from around the globe, fostering collaboration and knowledge exchange in the field of urology. Attendees experienced a comprehensive scientific program featuring renowned experts who addressed contemporary challenges and advancements in urological care.
This year’s congress showcased an exceptional lineup of educational sessions, including live surgery courses, workshops, and the highly anticipated 6th Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting. With a focus on innovative therapeutic strategies and multidisciplinary approaches, the congress aimed to enhance patient care and outcomes in urological oncology.
Set against the backdrop of New Delhi’s rich history and cultural diversity, the SIU 2024 Congress offered a unique opportunity for networking, learning, and exploring cutting-edge developments in urology. Participants not only gained insights into the latest research but also experienced the warmth and hospitality of India’s capital city. The event served as a landmark occasion that inspired and elevated the field of urology!
Dr. Shilpa Gupta is the Director of Genitourinary Oncology, a staff member in Hematology and Oncology and a Professor of Medicine at Cleveland Clinic. Dr. Gupta shared some of the insights from the conference, on X:
“Happening now! Masterclass in NMIBC with world class faculty!
Definition of NMIBC intermediate risk IBCG by Ashish M. Kamat.
Use of BCG and post BCG treatment experience in India and globally by Gagan Prakash.
Novel Treatment options in BCG refractory NMIBC by Andrea Necchi who has been at the forefront of drug development in this space.”
Gagan Prakash giving a beautiful background of evolution of BCG in NMIBC & MOA of the “original immunotherapy” which still has not been beat in NMIBC.
Discusses the quest for newer starting of BCG driven by BCG shortage.”
“This master and sobering slide by Andrea Necchi summarizes the shocking disparities in the treatment options for a patient with NMIBC depending on geographical location!
We need to fix this; academia and industry need to work together to bring drugs to the rest of the world at affordable prices.”
“Simon Tanguay and Peter Black kicking off the B2BGU Cancers Triad sessions!
A diverse list of topics across GU cancers with stellar line up of speakers!
Seth Lerner, Karima Oualla, Gagan Prakash, Vedang Murthy, Mihir Desai and many others!
Happening now in Ballroom 2.”
“Co-chair, Peter Black, beautifully tackles the intriguing topic of subtypes in bladder cancer, prognostic, predictive value & treatment implications to offer personalized therapy to patients.
SWOG Cancer Research Network leading a huge effort SubTyping trial in this space with Seth Lerner and Joshua Meeks.”
Hot Topic on integrative multi-D approaches to bladder preservation chaired by Adam Feldman.
The one & only Andrea Necchi gave an amazing talk on precision oncology approaches with VI-RADS MRI, ctDNA, need to define cCR for pts to allow successful bladder preservation.
“Thanks Seth Lerner for such an outstanding SIU-Urology 2024, New Delhi.
The breadth & diversity of the topics & controversies led by global faculty was simply amazing!
Kudos Team and Rajeev Kumar for your world class hospitality and making the meeting so memorable!”
Dr. Shilpa Gupta is the Director of Genitourinary Oncology, a staff member in Hematology and Oncology and a Professor of Medicine at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.
For more posts featuring Shilpa Gupta, follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023